P. Reed Maurer's articles"It's Worth Doing: Perspectives on the Japan Pharmaceutical Industry"is now available at Amazon.com or directly from the IAL office.
P. Reed Maurer's articles
"It's Worth Doing: Perspectives on the Japan Pharmaceutical Industry"is
now available at Amazon.com or directly from the IAL office.
as of May 14, 2012
| # | Title | Magazine | Month of Publishing |
| 124 | Impact of Japanese Price Reductions | The Pharma Letter | May 12, 2012 |
| 123 | Questions, Questions, Questions | Pharma Japan | Mar. 26, 2012 |
| 122 | Most Admired Pharma Companies in Japan | Pharma Japan | Mar. 12, 2012 |
| 121 | Another Look at Boiled Frogs | Pharma Japan | Feb. 27, 2012 |
| 121 | You've Got to Love This Market | Pharma Japan | Jan. 30, 2012 |
| 120 | Where Are We Going? | Pharma Japan | Dec. 2011& Jan. 2012 |
| 191 | Where Has All the Passion Gone? | Pharma Japan | Dec. 12, 2011 |
| 190 | Local Companies Want to Buy | Pharma Japan | Nov. 21, 2011 |
| 189 | Japan generics market:Boom or Bust? | The Pharma Letter | Nov. 17, 2011 |
| 188 | Japanese pharma companies set to go global | The Pharma Letter | Nov. 11, 2011 |
| 187 | Negatives of the Japan Pharma Market | Pharma Japan | Oct. 17, 2011 |
| 186 | It Helps to Know the Numbers | Phrama Japan | Sep. 12, 2011 |
| 185 | What Happens When... | Pharma Japan | Aug. 15 & 22, 2011 |
| 184 | Action Trumps No Action | Pharma Japan | Aug. 1, 2011 |
| 183 | News to Amuse and Abuse | Pharma Japan | Jul. 11, 2011 |
| 182 | Pharma Companies in Japan | Pharma Japan | May 30, 2011 |
| 181 | The Perils of Licdnsing Out | Pharma Japan | Apr. 18, 2011 |
| 180 | Japan's Most Admired Pharma Companies in 2010 | Pharma Japan | Apr. 4, 2011 |
| 179 | Another Shujutsu | Pharma Japan | Jan. 24, 2011 |
| 178 | 10 Reasons for Optimism in 2011 | Pharma Japan | Jan. 3, 2011 |
| 177 | 10 Bad Business Decisions | Pharma Japan | Dec. 13, 2010 |
| 176 | Seeds But No Place to Grow | Pharma Japan | Nov. 29, 2010 |
| 175 | Do You See What I See? | Pharma Japan | Nov. 8, 2010 |
| 174 | Home Office Friends or Back Stabbers | Pharma Japan | Oct. 25, 2010 |
| 173 | What's Going On? | Pharma Japan | Oct. 11, 2010 |
| 172 | The Tako Tsubo Factor | Pharma Japan | Jul. 12, 2010 |
| 171 | The Galapagos Factor | Pharma Japan | May 31, 2010 |
| 170 | All The News Unfit To Print | Pharma Japan | May 3 & 10, 2010 |
| 169 | Who Would Have Thought? | Pharma Japan | Apr., 2010 |
| 168 | Takeda Loses Sole Lead Among Admired Companies | Pharma Japan | Mar., 2010 |
| 167 | Distribution Reform - What Is Left Undone | Pharma Japan | Mar., 2010 |
| 166 | Be Careful What You Wish For | Pharma Japan | Dec., 2009&Jan., 2010 |
| 165 | Foreingers' Edge | Pharma Japan | Dec., 2009 |
| 164 | 10 Questions Frequently Asked | Pharma Japan | Nov., 2009 |
| 163 | Japan Pharma Industry Reform | Pharma Japan | Nov., 2009 |
| 162 | Can Bioventures Succeed in Japan? | Pharma Japan | Oct., 2009 |
| 161 | Evertbody Talks About Change | Pharma Japan | Oct., 2009 |
| 160 | Gaishi-Kei Are on a Roll | Pharma Japan | Sep., 2009 |
| 159 | The Devil Is in the Details | Pharma Japan | Aug., 2009 |
| 158 | I Am Losing It | Pharma Japan | Jul., 2009 |
| 157 | Three Berry Cuts and Consulting | Pharma Japan | Jun., 2009 |
| 156 | Too Long or Not Long Enough | Pharma Japan | May, 2009 |
| 155 | What Do You Want To Be? | Pharma Japan | Apr., 2009 |
| 154 | Interview-IyakuKeizai (Japanese) | IyakuKeizai | Apr., 2009 |
| 153 | Change and Hybrid | Pharma Japan | Mar, 2009 |
| 152 | Machiavellian Thoughts about Japan | Pharma Japan | Mar., 2009 |
| 151 | Japan's most-admired pharmaceutical companies in 2008 | MarketLetter | Feb., 2009 |
| 150 | Japan's Most Admired Pharma Companies in 2008 | Pharma Japan | Feb., 2009 |
| 149 | Tug of War | Pharma Japan | Jan., 2009 |
| 148 | What to Hope for in 2009 | Pharma Japan | Dec,. 2008 & Jan., 2009 |
| 147 | 2008: Contemplate the Changes | Pharma Japan | Dec., 2008 |
| 146 | Loving the Japan Pharma Market | Pharma Japan | Dec., 2008 |
| 145 | Foreign Pharma Challenges In Japan | Pharma Japan | Oct., 2008 |
| 144 | All the News Unfit to Print | Pharma Japan | Sep., 2008 |
| 143 | The Mysteries of Japan Pharma | Pharma Japan | Aug., 2008 |
| 142 | Back to the Numbers | Pharma Japan | Jul., 2008 |
| 141 | The Fate of Small Pharma Companies | Pharma Japan | Jun., 2008 |
| 140 | Will Japan Reward Innovation? | Pharma Japan | May,. 2008 |
| 139 | Double in Five Years? | Pharma Japan | Mar., 2008 |
| 138 | Japan's Most Admired Companies in 2007 | Pharma Japan | Mar., 2008 |
| 137 | A Family Affair | Pharma Japan | Feb., 2008 |
| 136 | Downsizing US Style | Pharma Japan | Jan., 2008 |
| 135 | M&A Japanese Style | Pharma Japan | Dec., 2007 |
| 134 | What Has Changed? | Pharma Japan | Nov.,2007 |
| 133 | Optimism Is Alive and Well | Pharma Japan | Oct., 2007 |
| 132 | All the News Unfit to Print | Pharma Japan | Aug., 2007 |
| 131 | Japan Is (Is Not) an Attractive Market Part 2 | Pharma Japan | Jun., 2007 |
| 130 | Japan Is Not (Is) an Attractive Market Part 1 | Pharma Japan | May., 2007 |
| 129 | Updating the Numbers | Pharma Japan | Apr., 2007 |
| 128 | A Tough Look Back at 2006 | Pharma Japan | Mar., 2007 |
| 127 | The 2006 most admired pharmaceutical comapnies in Japan | Market Letter | Mar., 2007 |
| 126 | Japan's Most Admired Pharma Companies in 2006 | Pharma Japan | Mar., 2007 |
| 125 | Count Your Blessings | Pharma Japan | Feb., 2007 |
| 124 | 2006: When The Pendulum Swung | Pharma Japan | Jan., 2007 |
| 123 | Questions from the Floor | Pharma Japan | Dec., 2006 |
| 122 | Feedback Is My Nutrition | Pharma Japan | Nov., 2006 |
| 121 | One More Time: Numbers to Contemplate | Pharma Japan | Oct., 2006 |
| 120 | Back from the Saddle | Pharma Japan | Sep., 2006 |
| 119 | Infinite Value of a Good Boss | Pharma Japan | Aug., 2006 |
| 118 | Hooray for People in Healthcare | Pharma Japan | Jul., 2006 |
| 117 | Roppongi Cleanup - An Organizational Lesson | Pharma Japan | Jun., 2006 |
| 116 | Who Owns Japan's Pharma Companies? | Pharma Japan | May., 2006 |
| 115 | All the News Unfit to Print | Pharma Japan | Apr., 2006 |
| 114 | Stop and Go Gets You Nowhere | Pharma Japan | Mar, 2006 |
| 113 | Japan's Most Admired Pharma Companies | Pharma Japan & Market Letter | Feb. & Mar., 2006 |
| 112 | Have You Been Here Too Long? | Pharma Japan | Jan., 2006 |
| 111 | Surprise Free Forecasts For 2006 | Pharma Japan | Jan., 2006 |
| 110 | The "New" Japanese Corporation | Pharma Japan | Dec., 2005 |
| 109 | M&A Risks | Pharma Japan | Nov., 2005 |
| 108 | Remember History to Avoid Repeating It | Pharma Japan | Nov., 2005 |
| 107 | News Unfit to Print | Pharma Japan | Oct., 2005 |
| 106 | Myths We Believe Versus Reality | Pharma Japan | Sep., 2005 |
| 105 | All You Ever Wanted to Know | Pharma Japan | Aug., 2005 |
| 104 | So You Think Nothing Changes | Pharma Japan | Jul., 2005 |
| 103 | Does Japan Change? | Market Letter | Jul., 2005 |
| 102 | All the News Unfit to Print | Pharma Japan | Jun., 2005 |
| 101 | How to Become a Japanese Doctor | Pharma Japan | May, 2005 |
| 100 | Emerging Company Innovation, Focus, and Speed | Market Letter | May, 2005 |
| 99 | Japan Pharma Consolidates to Globalize | Market Letter | May, 2005 |
| 98 | To Be or Not to Be | Pharma Japan | Apr. & May, 2005 |
| 97 | Japan's Most Admired Pharma Companies | Pharma Japan & Market Letter | Apr., 2005 |
| 96 | Same New - Different Stories | Pharma Japan | Mar., 2005 |
| 95 | Go West Young Man | Pharma Japan | Mar., 2005 |
| 94 | Challenges Ahead for Everyone | Pharma Japan | Jan., 2005 |
| 93 | The 3C's of Success | Pharma Japan | Dec., 2004 |
| 92 | Foreign Managers for Japanese Companies | Pharma Japan | Nov., 2004 |
| 91 | Numbers Worth Pondering | Pharma Japan | Oct., 2004 |
| 90 | Warning Signs for Foreign Executives | Pharma Japan | Sep., 2004 |
| 89 | Forty Years as Prelude | Pharma Japan | Jul., 2004 |
| 88 | Pharma Consolidation: A Cure or Disease? | Pharma Japan | May, 2004 |
| 87 | OTC Market: Slow Decline or Revival? | Pharma Japan | Apr., 2004 |
| 86 | Retrospective on Growth: 1994-2004 | Pharma Japan | Mar., 2004 |
| 85 | Most Admired Pharma Companies in Japan | Market Letter | Mar., 2004 |
| 84 | Most Admired Pharma Companies in Japan | Pharma Japan | Mar., 2004 |
| 83 | Drug Pricing: A Personal Experience | Pharma Japan | Feb., 2004 |
| 82 | Resolutions | Pharma Japan | Jan., 2004 |
| 81 | Surprise-Free 2004 Predictions | Pharma Japan | Dec. 2003 & Jan., 2004 |
| 80 | Wholesalers at the Crossroads | Pharma Japan | Dec., 2003 |
| 79 | FY03/04 So Far More Questions Than Answers | Pharma Japan | Nov., 2003 |
| 78 | Japan: Home Away from Home | Pharma Japan | Oct., 2003 |
| 77 | Japan Pharma Will (Must?) Restructure | Scrip Magazine | Oct., 2003 |
| 76 | Some Restructuring Models Work - Others Don't | Pharma Japan | Sep., 2003 |
| 75 | A Trip Down Memory Lane | Pharma Japan | Aug., 2003 |
| 74 | Things Not Talked About Anymore | Pharma Japan | Jul., 2003 |
| 73 | Back To The Numbers | Pharma Japan | Jun., 2003 |
| 72 | Foreign Companies Crack Japan Pharma Market | Pharma Japan | May, 2003 |
| 71 | Foreign Pharma Shock and Awe | Pharma Japan | May, 2003 |
| 70 | Health Reform: Much Ado About Nothing? | Pharma Japan | Apr. & May, 2003 |
| 69 | Pros Focus on Differences | Pharma Japan | Apr., 2003 |
| 68 | The View of M&A in Japan | Pharma Japan | Mar., 2003 |
| 67 | Japan's Most Admired Pharma Companies in 2002 | Pharma Japan | Mar., 2003 |
| 66 | Q&A | Pharma Japan | Jan., 2003 |
| 65 | S&M Led to S&D then to R&D | Pharma Japan | Jan., 2003 |
| 64 | 2003: Integration to Disintegration | Pharma Japan | Jan., 2003 |
| 63 | Japan Pharma Industry Eschews In-House Manufacturing | Market Letter | Dec., 2002 |
| 62 | Has the Time Come for Generics? | Pharma Japan | Dec., 2002 |
| 61 | Manufacturing Going, Going, Gone | Pharma Japan | Nov., 2002 |
| 60 | Will Japan Consolidate Its Pharmaceutical Industry? | Market Letter | Oct., 2002 |
| 59 | Are the Assumptions Correct? | Pharma Japan | Oct, 2002 |
| 58 | What Drives You Up the Wall? | Pharma Japan | Sep., 2002 |
| 57 | I Want Control (Of What?) | Pharma Japan | Aug., 2002 |
| 56 | Japan Pharma World Turned Upside Down | Pharma Japan | Jul., 2002 |
| 55 | Self-Inflicted Pain | Pharma Japan | Jul., 2002 |
| 54 | Korosho Wedding Will Curb Internationalization | Pharma Japan | Jun., 2002 |
| 53 | Alliances Bloom. M&A Withers | Pharma Japan | May, 2002 |
| 52 | Who Owns Japan's Pharma Companies? | Pharma Japan | Apr.& May, 2002 |
| 51 | Too Many Boiled Frogs | Pharma Japan | Apr., 2002 |
| 50 | Once Again Back to the Numbers | Pharma Japan | Mar., 2002 |
| 49 | Out with the Old | Pharma Japan | Feb. ,2002 |
| 48 | Disasters That Never Come | Pharma Japan | Jan., 2002 |
| 47 | Japan's Most Admired Pharmaceutical Companies | Pharma Japan | Nov., 2001 |
| 46 | Good Management Is Obvious | Pharma Japan | Nov., 2001 |
| 45 | Beware of Collective Wisdom | Pharma Japan | Oct., 2001 |
| 44 | Enjoy It While It Lasts | Pharma Japan | Oct., 2001 |
| 43 | Change And Reinvention Through 2005 | Pharma Japan | Sep., 2001 |
| 42 | Reinventing Japan's Pharmaceutical Industry (6) | Iyaku Keizaisha | Sep., 2001 |
| 41 | Intercompany Restructuring: Inevitable or Impossible? | Pharma Japan | Sep., 2001 |
| 40 | Reinventing Japan's Pharmaceutical Industry (5) | Iyaku Keizaisha | Sep., 2001 |
| 39 | Foreign Company Partners Become Competitors | Pharma Japan | Aug., 1001 |
| 38 | Reinventing Japan's Pharmaceutical Industry (4) | Iyaku Keizaisha | Aug., 2001 |
| 37 | Wholesalers Revise Their Business Models | Pharma Japan | Jul., 2001 |
| 36 | Reinventing Japan's Pharmaceutical Industry (3) | Iyaku Keizaisha | Jul.,2001 |
| 35 | Reinventing Japan's Pharmaceutical Industry (2) | Iyaku Keizaisha | Jul., 2001 |
| 34 | Why Japan Is (Still) Important | Pharma Japan | Jun., 2001 |
| 33 | Reinventing Japan's Pharmaceutical Industry (1) | Iyaku Keizaisha | Jun., 2001 |
| 32 | Things I Don't Know --- But | Pharma Japan | May, 2001 |
| 31 | Checking the Pulse of Japan's Healthcare | Pharma Japan | Apr., 2001 |
| 30 | Like Taking Candy from a Baby | Pharma Japan | Mar., 2001 |
| 29 | The Other Side of the Story | Pharma Japan | Mar., 2001 |
| 28 | 2001: A Bridge to the Future | Pharma Japan | Jan., 2001 |
| 27 | Mind Blocks Preventing Change | Pharma Japan | Dec., 2000 |
| 26 | Japan's Most Admired Pharmaceutical Companies | Pharma Japan | Oct., 2000 |
| 25 | Malaise | Pharma Japan | Oct., 2000 |
| 24 | Facts - Nothing But the Facts | Pharma Japan | Sep., 2000 |
| 23 | Learn the Basic | Pharma Japan | Aug., 2000 |
| 22 | Commentary on the News | Pharma Japan | Jul., 2000 |
| 21 | Win by Staying on the Field | Pharma Japan | Jul., 2000 |
| 20 | Dobyo Ai Awaremu | Pharma Japan | Jun., 2000 |
| 19 | GO ni itte wa, GO ni shitagae | Pharma Japan | May, 2000 |
| 18 | Destructuring of the Pharmaceutical Industry | Pharma Japan | Apr., 2000 |
| 17 | Don't Make Me Say No | Pharma Japan | Jan., 2000 |
| 16 | Don't Look Back | Pharma Japan | Jan., 2000 |
| 15 | 100 Views from Tokyo | Pharma Japan | Dec., 1999 |
| 14 | Reinventing Japan's Health Care System | ACCJ Journal | Oct., 1999 |
| 13 | Japan's Most Admired Pharmaceutical Company | Market Letter | Aug., 1999 |
| 12 | Japanese Integrated Company Models Are Doomed | Pharma Japan | Aug., 1999 |
| 11 | Foreign Company Blunders Taint Everyone | Pharma Japan | Jul., 1999 |
| 10 | Market Axioms to Live by | Pharma Japan | Jul.,1999 |
| 9 | Why Japanese Pharmaceutical Wholesalers Merge | Market Letter | Jun., 1999 |
| 8 | Japanese Pharmaceutical Firms Struggle to Restructure | Market Letter | May, 1999 |
| 7 | M&A Prospects in Japan | Market Letter | Dec., 1998 |
| 6 | Contract MRs Will Fail in Japan (3) | Iyaku Keizaisha | Nov., 1998 |
| 5 | Contract MRs Will Fail in Japan (2) | Iyaku Keizaisha | Nov., 1998 |
| 4 | Contract MRs Will Fail in Japan (1) | Iyaku Keizaisha | Nov., 1998 |
| 3 | How to Crack the Japanese Pharmaceutical Market | Market Letter | Oct., 1998 |
| 2 | Japanese Market Collapse - Is It Permanent? | Market Letter | Apr., 1998 |
| 1 | Understanding Japan's Changing Rules | Scrip Magazine | Feb., 1998 |
